ArticleContemporary clinical trials communications2024

Hydroxyurea therapy for neurological and cognitive protection in pediatric sickle cell anemia in Uganda (BRAIN SAFE II): Protocol for a single-arm open label trial.

Vincent Mboizi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.